Table of Contents Author Guidelines Submit a Manuscript
International Journal of Cell Biology
Volume 2011, Article ID 978583, 11 pages
http://dx.doi.org/10.1155/2011/978583
Research Article

Stable Differences in Intrinsic Mitochondrial Membrane Potential of Tumor Cell Subpopulations Reflect Phenotypic Heterogeneity

Department of Oncology, Albert Einstein Cancer Center, Montefiore Medical Center, 111 East 210th Street, Bronx, NY 10467, USA

Received 15 March 2011; Revised 4 May 2011; Accepted 6 May 2011

Academic Editor: Paul Higgins

Copyright © 2011 Michele A. Houston et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. J. Altschuler and L. F. Wu, “Cellular heterogeneity: do differences make a difference?” Cell, vol. 141, no. 4, pp. 559–563, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. J. S. Modica-Napolitano, G. D. Steele, and L. B. Chen, “Aberrant mitochondria in two human colon carcinoma cell lines,” Cancer Research, vol. 49, no. 12, pp. 3369–3373, 1989. View at Google Scholar · View at Scopus
  3. A. S. Sun, K. Sepkowitz, and S. A. Geller, “A study of some mitochondrial and peroxisomal enzymes in human colonic adenocarcinoma,” Laboratory Investigation, vol. 44, no. 1, pp. 13–17, 1981. View at Google Scholar · View at Scopus
  4. M. Kulawiec, K. M. Owens, and K. K. Singh, “MtDNA G10398A variant in African-American women with breast cancer provides resistance to apoptosis and promotes metastasis in mice,” Journal of Human Genetics, vol. 54, no. 11, pp. 647–654, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. I. C. Summerhayes, T. J. Lampidis, S. D. Bernal et al., “Unusual retention of rhodamine 123 by mitochondria in muscle and carcinoma cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 79, no. 17, pp. 5292–5296, 1982. View at Google Scholar · View at Scopus
  6. L. B. Chen, “Mitochondrial membrane potential in living cells,” Annual Review of Cell Biology, vol. 4, pp. 155–181, 1988. View at Google Scholar · View at Scopus
  7. L. B. Chen and E. N. Rivers, “Mitochondria in cancer cells,” in Genes and Cancer, D. Carney and K. Sikora, Eds., pp. 127–135, John Wiley & Sons, 1990. View at Google Scholar
  8. J. R. Wong and L. B. Chen, “Recent advances in the study of mitochondria in living cells,” Advances in Molecular and Cell Biology, vol. 2, pp. 263–290, 1988. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Davis, M. J. Weiss, and J. R. Wong, “Mitochondrial and plasma membrane potentials cause unusual accumulation and retention of rhodamine 123 by human breast adenocarcinoma-derived MCF-7 cells,” Journal of Biological Chemistry, vol. 260, no. 25, pp. 13844–13850, 1985. View at Google Scholar · View at Scopus
  10. A. Leibovitz, J. C. Stinson, W. B. McCombs III, C. E. McCoy, K. C. Mazur, and N. D. Mabry, “Classification of human colorectal adenocarcinoma cell lines,” Cancer Research, vol. 36, no. 12, pp. 4562–4569, 1976. View at Google Scholar
  11. B. G. Heerdt, M. A. Houston, and L. H. Augenlicht, “The intrinsic mitochondrial membrane potential of colonic carcinoma cells is linked to the probability of tumor progression,” Cancer Research, vol. 65, no. 21, pp. 9861–9867, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. H. D. Soule, J. Vazquez, and A. Long, “A human cell line from a pleural effusion derived from a breast carcinoma,” Journal of the National Cancer Institute, vol. 51, no. 5, pp. 1409–1416, 1973. View at Google Scholar
  13. H. Schöllnberger, N. Beerenwinkel, R. Hoogenveen, and P. Vineis, “Cell selection as driving force in lung and colon carcinogenesis,” Cancer Research, vol. 70, no. 17, pp. 6797–6803, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. B. G. Heerdt, M. A. Houston, A. J. Wilson, and L. H. Augenlicht, “The intrinsic mitochondrial membrane potential (ΔΨm) is associated with steady-state mitochondrial activity and the extent to which colonic epithelial cells undergo butyrate-mediated growth arrest and apoptosis,” Cancer Research, vol. 63, no. 19, pp. 6311–6319, 2003. View at Google Scholar · View at Scopus
  15. B. G. Heerdt, M. A. Houston, J. M. Mariadason, and L. H. Augenlicht, “Dissociation of staurosporine-induced apoptosis from G2-M arrest in SW620 human colonic carcinoma cells: initiation of the apoptotic cascade is associated with elevation of the mitochondrial membrane potential (ΔΨm),” Cancer Research, vol. 60, no. 23, pp. 6704–6713, 2000. View at Google Scholar · View at Scopus
  16. B. G. Heerdt, M. A. Houston, G. M. Anthony, and L. H. Augenlicht, “Initiation of growth arrest and apoptosis of MCF-7 mammary carcinoma cells by tributyrin, a triglyceride analogue of the short-chain fatty acid butyrate, is associated with mitochondrial activity,” Cancer Research, vol. 59, no. 7, pp. 1584–1591, 1999. View at Google Scholar · View at Scopus
  17. B. G. Heerdt, M. A. Houston, G. M. Anthony, and L. H. Augenlicht, “Mitochondrial membrane potential (ΔΨmt) in the coordination of p53-independent proliferation and apoptosis pathways in human colonic carcinoma cells,” Cancer Research, vol. 58, no. 13, pp. 2869–2875, 1998. View at Google Scholar · View at Scopus
  18. T. Mosmann, “Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays,” Journal of Immunological Methods, vol. 65, no. 1-2, pp. 55–63, 1983. View at Google Scholar · View at Scopus
  19. M. Reers, “J-aggregate formation of a carbocyanine as a quantitative fluorescent indicator of membrane potential,” Biochemistry, vol. 30, no. 18, pp. 4480–4486, 1991. View at Google Scholar · View at Scopus
  20. B. G. Heerdt, M. A. Houston, and L. H. Augenlicht, “Growth properties of colonic tumor cells are a function of the intrinsic mitochondrial membrane potential,” Cancer Research, vol. 66, no. 3, pp. 1591–1596, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. W. E. W. Roediger, “Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man,” Gut, vol. 21, no. 9, pp. 793–798, 1980. View at Google Scholar · View at Scopus
  22. J. H. Cummings, “Fermentation in the human large intestine: evidence and implications for health,” The Lancet, vol. 1, no. 8335, pp. 1206–1209, 1983. View at Google Scholar · View at Scopus
  23. H. Schulz, “Oxidation of fatty acids,” in Biochemistry of Lipids and Membranes, D. E. Vance and J. E. Vance, Eds., pp. 116–142, Benjamin/Cummings, Reading, Mass, USA, 1985. View at Google Scholar
  24. W. E.W. Roediger, “Utilization of nutrients by isolated epithelial cells of the rat colon,” Gastroenterology, vol. 83, no. 2, pp. 424–429, 1982. View at Google Scholar
  25. B. G. Heerdt, M. A. Houston, and L. H. Augenlicht, “Potentiation by specific short-chain fatty acids of differentiation and apoptosis in human colonic carcinoma cell lines,” Cancer Research, vol. 54, no. 12, pp. 3288–3294, 1994. View at Google Scholar · View at Scopus
  26. W. E. W. Roediger, “Bacterial short-chain fatty acids and mucosal diseases of the colon,” British Journal of Surgery, vol. 75, no. 4, pp. 346–348, 1988. View at Google Scholar · View at Scopus
  27. L. H. Augenlicht, G. M. Anthony, T. L. Church et al., “Short-chain fatty acid metabolism, apoptosis, and Apc-initiated tumorigenesis in the mouse gastrointestinal mucosa,” Cancer Research, vol. 59, no. 23, pp. 6005–6009, 1999. View at Google Scholar · View at Scopus
  28. J. M. Mariadason, G. A. Corner, and L. H. Augenlicht, “Genetic reprogramming in pathways of colonic cell maturation induced by short chain fatty acids: comparison with trichostatin A, sulindac, and curcumin and implications for chemoprevention of colon cancer,” Cancer Research, vol. 60, no. 16, pp. 4561–4572, 2000. View at Google Scholar · View at Scopus
  29. V. Medina, J. J. Afonso, H. Alvarez-Argijelles, C. Hernandez, and F. Gonzalez, “Sodium butyrate inhibits carcinoma development in a 1,2-dimethylhydrazine-induced rat colon cancer,” Journal of Parenteral and Enteral Nutrition, vol. 22, no. 1, pp. 14–17, 1998. View at Google Scholar · View at Scopus
  30. G. D'Argenio, V. Cosenza, M. Delle Cave et al., “Butyrate enemas in experimental colitis and protection against large bowel cancer in a rat model,” Gastroenterology, vol. 110, no. 6, pp. 1727–1734, 1996. View at Publisher · View at Google Scholar · View at Scopus
  31. A. McIntyre, P. R. Gibson, and G. P. Young, “Butyrate production from dietary fibre and protection against large bowel cancer in a rat model,” Gut, vol. 34, no. 3, pp. 386–391, 1993. View at Google Scholar · View at Scopus
  32. P. Planchon, H. Raux, V. Magnien et al., “New stable butyrate derivatives alter proliferation and differentiation in human mammary cells,” International Journal of Cancer, vol. 48, no. 3, pp. 443–449, 1991. View at Google Scholar · View at Scopus
  33. M. Mandal and R. Kumar, “Bcl-2 expression regulates sodium butyrate-induced apoptosis in human MCF-7 breast cancer cells,” Cell Growth and Differentiation, vol. 7, no. 3, pp. 311–318, 1996. View at Google Scholar · View at Scopus
  34. A. Novagrodsky, A. Ovir, A. Ravid et al., “Effect of polar organic compounds in leukemia cells. Butyrate-induced partial remission of acute myalogenous leukemia in a child,” Cancer, vol. 51, pp. 9–14, 1983. View at Google Scholar
  35. A. A. Miller, E. Kurschel, R. Osieka, and C. G. Schmidt, “Clinical pharmacology of sodium butyrate in patients with acute leukemia,” European Journal of Cancer and Clinical Oncology, vol. 23, no. 9, pp. 1283–1287, 1987. View at Google Scholar · View at Scopus
  36. H. L. Newmark, J. R. Lupton, and C. W. Young, “Butyrate as a differentiating agent: pharmacokinetics, analogues and current status,” Cancer Letters, vol. 78, no. 1-3, pp. 1–5, 1994. View at Google Scholar · View at Scopus
  37. Z. Yuan, J. Eiseman, K. Plasance et al., “Plasma pharmacoinetics of butyrate after the administration of tributyrin and Na butyrate to mice and rats,” Proceedings of the American Association for Cancer Research, vol. 35, p. 429, 1994. View at Google Scholar
  38. J. H. Cummings, E. W. Pomare, W. J. Branch, C. P. E. Naylor, and G. T. Macfarlane, “Short chain fatty acids in human large intestine, portal, hepatic and venous blood,” Gut, vol. 28, no. 10, pp. 1221–1227, 1987. View at Google Scholar · View at Scopus
  39. N. Ferrara, “Vascular endothelial growth factor: basic science and clinical progress,” Endocrine Reviews, vol. 25, no. 4, pp. 581–611, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. G. Bergers and L. E. Benjamin, “Tumorigenesis and the angiogenic switch,” Nature Reviews Cancer, vol. 3, no. 6, pp. 401–410, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. D. J. Hicklin and L. M. Ellis, “Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis,” Journal of Clinical Oncology, vol. 23, no. 5, pp. 1011–1027, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. T. Tokunaga, Y. Oshika, Y. Abe et al., “Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancer,” British Journal of Cancer, vol. 77, no. 6, pp. 998–1002, 1998. View at Google Scholar · View at Scopus
  43. M. Kioi, K. Yamamoto, S. Higashi, N. Koshikawa, K. Fujita, and K. Miyazaki, “Matrilysin (MMP-7) induces homotypic adhesion of human colon cancer cells and enhances their metastatic potential in nude mouse model,” Oncogene, vol. 22, no. 54, pp. 8662–8670, 2003. View at Publisher · View at Google Scholar · View at Scopus
  44. Y. Ichikawa, T. Ishikawa, N. Momiyama et al., “Detection of regional lymph node metastases in colon cancer by using RT-PCR for matrix metalloproteinase 7, matrilysin,” Clinical and Experimental Metastasis, vol. 16, no. 1, pp. 3–8, 1998. View at Publisher · View at Google Scholar · View at Scopus
  45. M. Mori, G. F. Barnard, K. Mimori, H. Ueo, T. Akiyoshi, and K. Sugimachi, “Overexpression of matrix metalloproteinase-7 mRNA in human colon carcinomas,” Cancer, vol. 75, no. 6, pp. 1516–1519, 1995. View at Google Scholar · View at Scopus
  46. J. P. Witty, S. McDonnell, K. J. Newell et al., “Modulation of matrilysin levels in colon carcinoma cell lines affects tumorigenicity in vivo,” Cancer Research, vol. 54, no. 17, pp. 4805–4812, 1994. View at Google Scholar · View at Scopus
  47. B. Y. Ho, Y. M. Wu, Y. W. Hsu et al., “Effects of monascus-fermented rice extract on malignant cell-associated neovascularization and intravasation determined using the chicken embryo chorioallantoic membrane model,” Integrative Cancer Therapies, vol. 9, no. 2, pp. 204–212, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. F. Wang, S. Reierstad, and D. A. Fishman, “Matrilysin over-expression in MCF-7 cells enhances cellular invasiveness and pro-gelatinase activation,” Cancer Letters, vol. 236, no. 2, pp. 292–301, 2006. View at Publisher · View at Google Scholar · View at Scopus
  49. A. U. Jawhari, A. Buda, M. Jenkins et al., “Fascin, an actin-bundling protein, modulates colonic epithelial cell invasiveness and differentiation in vitro,” American Journal of Pathology, vol. 162, no. 1, pp. 69–80, 2003. View at Google Scholar · View at Scopus
  50. Y. Hashimoto, M. Skacel, I. C. Lavery, A. L. Mukherjee, G. Casey, and J. C. Adams, “Prognostic significance of fascin expression in advanced colorectal cancer: an immunohistochemical study of colorectal adenomas and adenocarcinomas,” BMC Cancer, vol. 6, article 241, 2006. View at Publisher · View at Google Scholar · View at Scopus
  51. P. Goldman, “The carbon-fluorine bond in compounds of biological interest,” Science, vol. 164, no. 3884, pp. 1123–1130, 1969. View at Google Scholar · View at Scopus
  52. B. G. Heerdt and L. H. Augenlicht, “Effects of fatty acids on expression of genes encoding subunits of cytochrome c oxidase and cytochrome c oxidase activity in HT29 human colonic adenocarcinoma cells,” Journal of Biological Chemistry, vol. 266, no. 28, pp. 19120–19126, 1991. View at Google Scholar · View at Scopus
  53. M. Bordonaro, J. M. Mariadason, F. Aslam, B. G. Heerdt, and L. H. Augenlicht, “Butyrate-induced apoptotic cascade in colonic carcinoma cells: modulation of the β-catenin-Tcf pathway and concordance with effects of sulindac and trichostatin A but not curcumin,” Cell Growth and Differentiation, vol. 10, no. 10, pp. 713–720, 1999. View at Google Scholar · View at Scopus
  54. A. King, M. A. Selak, and E. Gottlieb, “Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer,” Oncogene, vol. 25, no. 34, pp. 4675–4682, 2006. View at Publisher · View at Google Scholar · View at Scopus
  55. P. Koivunen, M. Hirsilä, A. M. Remes, I. E. Hassinen, K. I. Kivirikko, and J. Myllyharju, “Inhibition of hypoxia-inducible factor (HIF) hydroxylases by citric acid cycle intermediates: possible links between cell metabolism and stabilization of HIF,” Journal of Biological Chemistry, vol. 282, no. 7, pp. 4524–4532, 2007. View at Publisher · View at Google Scholar · View at Scopus
  56. P. J. Pollard, J. J. Brière, N. A. Alam et al., “Accumulation of Krebs cycle intermediates and over-expression of HIF1α in tumours which result from germline FH and SDH mutations,” Human Molecular Genetics, vol. 14, no. 15, pp. 2231–2239, 2005. View at Publisher · View at Google Scholar · View at Scopus
  57. M. A. Selak, S. M. Armour, E. D. MacKenzie et al., “Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase,” Cancer Cell, vol. 7, no. 1, pp. 77–85, 2005. View at Publisher · View at Google Scholar · View at Scopus
  58. S. M. Schieke, D. Phillips, J. P. McCoy Jr. et al., “The mammalian target of rapamycin (mTOR) pathway regulates mitochondrial oxygen consumption and oxidative capacity,” Journal of Biological Chemistry, vol. 281, no. 37, pp. 27643–27652, 2006. View at Publisher · View at Google Scholar · View at Scopus
  59. D. H. Kim, D. D. Sarbassov, S. M. Ali et al., “mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery,” Cell, vol. 110, no. 2, pp. 163–175, 2002. View at Publisher · View at Google Scholar · View at Scopus
  60. F. Jiang, M. T. Ryan, M. Schlame et al., “Absence of cardiolipin in the crd1 null mutant results in decreased mitochondrial membrane potential and reduced mitochondrial function,” Journal of Biological Chemistry, vol. 275, no. 29, pp. 22387–22394, 2000. View at Publisher · View at Google Scholar · View at Scopus
  61. M. Y. Hong, R. S. Chapkin, R. Barhoumi et al., “Fish oil increases mitochondrial phospholipid unsaturation, upregulating reactive oxygen species and apoptosis in rat colonocytes,” Carcinogenesis, vol. 23, no. 11, pp. 1919–1925, 2002. View at Google Scholar · View at Scopus
  62. F. M. Vaz, R. H. Houtkooper, F. Valianpour, P. G. Barth, and R. J. A. Wanders, “Only one splice variant of the human TAZ gene encodes a functional protein with a role in cardiolipin metabolism,” Journal of Biological Chemistry, vol. 278, no. 44, pp. 43089–43094, 2003. View at Publisher · View at Google Scholar · View at Scopus
  63. P. G. Barth, R. J. A. Wanders, and P. Vreken, “X-linked cardioskeletal myopathy and neutropenia (Barth syndrome)-MIM 302060,” Journal of Pediatrics, vol. 135, no. 3, pp. 273–276, 1999. View at Google Scholar · View at Scopus
  64. M. Schlame, R. I. Kelley, A. Feigenbaum et al., “Phospholipid abnormalities in children with Barth syndrome,” Journal of the American College of Cardiology, vol. 42, no. 11, pp. 1994–1999, 2003. View at Publisher · View at Google Scholar · View at Scopus
  65. Y. Xu, R. I. Kelley, T. J. J. Blanck, and M. Schlame, “Remodeling of cardiolipin by phospholipid transacylation,” Journal of Biological Chemistry, vol. 278, no. 51, pp. 51380–51385, 2003. View at Publisher · View at Google Scholar · View at Scopus
  66. H. Lu and X. Cao, “GRIM-19 is essential for maintenance of mitochondrial membrane potential,” Molecular Biology of the Cell, vol. 19, no. 5, pp. 1893–1902, 2008. View at Publisher · View at Google Scholar · View at Scopus
  67. Y. He, J. Wu, D. C. Dressman et al., “Heteroplasmic mitochondrial DNA mutations in normal and tumour cells,” Nature, vol. 464, no. 7288, pp. 610–614, 2010. View at Publisher · View at Google Scholar · View at Scopus
  68. K. Polyak, Y. Li, H. Zhu et al., “Somatic mutations of the mitochondrial genome in human colorectal tumours,” Nature Genetics, vol. 20, no. 3, pp. 291–293, 1998. View at Publisher · View at Google Scholar · View at Scopus
  69. W. Habano, S. I. Nakamura, and T. Sugai, “Microsatellite instability in the mitochondrial DNA of colorectal carcinomas: evidence for mismatch repair systems in mitochondrial genome,” Oncogene, vol. 17, no. 15, pp. 1931–1937, 1998. View at Google Scholar · View at Scopus
  70. W. Habano, T. Sugai, S. Nakamura, N. Uesugi, T. Yoshida, and S. Sasou, “Microsatellite instability and mutation of mitochondrial and nuclear DNA in gastric carcinoma,” Gastroenterology, vol. 118, no. 5, pp. 835–841, 2000. View at Google Scholar · View at Scopus
  71. M. Kulawiec, K. M. Owens, and K. K. Singh, “Cancer cell mitochondria confer apoptosis resistance and promote metastasis,” Cancer Biology & Therapy, vol. 8, no. 14, pp. 1378–1385, 2009. View at Google Scholar · View at Scopus
  72. K. Munakata, M. Tanaka, K. Mori et al., “Mitochondrial DNA 3644T→C mutation associated with bipolar disorder,” Genomics, vol. 84, no. 6, pp. 1041–1050, 2004. View at Publisher · View at Google Scholar · View at Scopus
  73. R. J. R. J. Janssen, L. G. Nijtmans, L. P. van den Heuvel, and J. A. M. Smeitink, “Mitochondrial complex I: structure, function and pathology,” Journal of Inherited Metabolic Disease, vol. 29, no. 4, pp. 499–515, 2006. View at Publisher · View at Google Scholar · View at Scopus
  74. A. Y. Abramov, T. K. Smulders-Srinivasan, D. M. Kirby et al., “Mechanism of neurodegeneration of neurons with mitochondrial DNA mutations,” Brain, vol. 133, no. 3, pp. 797–807, 2010. View at Publisher · View at Google Scholar · View at Scopus
  75. H. C. Lee, L. S. Hsu, P. H. Yin, L. M. Lee, and C. W. Chi, “Heteroplasmic mutation of mitochondrial DNA D-loop and 4977-bp deletion in human cancer cells during mitochondrial DNA depletion,” Mitochondrion, vol. 7, no. 1-2, pp. 157–163, 2007. View at Publisher · View at Google Scholar · View at Scopus
  76. A. Lièvre, C. Chapusot, A.-M. Bouvier et al., “Clinical value of mitochondrial mutations in colorectal cancer,” Journal of Clinical Oncology, vol. 23, no. 15, pp. 3517–3525, 2005. View at Publisher · View at Google Scholar
  77. G. F. Azzone, V. Petronilli, and M. Zoratti, “'Cross-talk' between redox- and ATP-driven H+ pumps,” Biochemical Society Transactions, vol. 12, no. 3, pp. 414–416, 1984. View at Google Scholar · View at Scopus
  78. V. R. Fantin, M. J. Berardi, L. Scorrano, S. J. Korsmeyer, and P. Leder, “A novel mitochondriotoxic small molecule that selectively inhibits tumor cell growth,” Cancer Cell, vol. 2, no. 1, pp. 29–42, 2002. View at Publisher · View at Google Scholar · View at Scopus
  79. A. M. Dorward and G. Singh, “Energetic characteristics of cisplatin resistant ovarian carcinoma cells,” Anticancer Research, vol. 16, no. 1, pp. 443–448, 1996. View at Google Scholar